Influenza is mainly transmitted through droplets of respiratory secretions, but also through direct or indirect contact with mucous membranes such as the mouth, nose, and eyes.

Recently, monitoring data from the World Health Organization showed that the intensity of the new coronavirus activity in Europe, the Americas and other regions has increased. As the novel coronavirus continues to mutate, the current novel coronavirus variants KP.2 and KP.1.1 have become dominant in these places.

According to multiple data, the total number of hospital admissions for COVID-19 cases reached 2,088 in the week ending Nov. 25, and more than 19,400 new hospitalizations of mycoplasma pneumoniae, meanwhile the RSV also entered the peak of infection.

The clinical application of a rapid detection for influenza A and B viruses, with the colloidal gold method, holds a significant importance in healthcare. Influenza viruses, especially types A and B, are responsible for seasonal outbreaks and can cause severe respiratory illnesses.

Mycoplasma pneumoniae, a microorganism that is distinct from bacteria, its size is between bacteria and viruses, and it arouses mycoplasma pneumoniae infection when it enters the human body.